Galecto Inc — Quarterly Dividends (NASDAQ:GLTO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

No data

News

Galecto rebrands as Damora Therapeutics, begins Nasdaq trading

UBS initiates Galecto stock with buy rating on blood disorder drug

Galecto shares fall after $275 million equity raise at discount

Galecto prices $275 million public offering at $19 per share

Galecto stock falls after announcing public offering of common stock

Galecto announces public offering of common stock and preferred shares

Galecto on track to submit IND for mutCALR antibody by mid-2026

Leerink Partners initiates coverage on Galecto stock with Outperform rating

Guggenheim raises Galecto stock price target to $36 on positive ASH25 data

Guggenheim initiates Galecto stock with Buy rating on DMR-001 potential

Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - BigBear.ai Hldgs (NYSE:BBAI), Aspire Biopharma Hldgs (NASDAQ:ASBP)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.81%